Related Experiment Video
Updated: May 31, 2026
A Fast and Reliable Pipeline for Bacterial Transcriptome Analysis Case study: Serine-dependent Gene Regulation in Streptococcus pneumoniae
Published on: April 25, 2015
A new microarray system to detect Streptococcus pneumoniae serotypes
Yuka Tomita1, Akira Okamoto, Keiko Yamada
1Department of Infectious Disease, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. yu-cat@med.nagoya-u.ac.jp
Abstract:
Streptococcus pneumoniae, one of the most common gram-positive pathogens to colonize the human upper respiratory tract, is responsible for many severe infections, including meningitis and bacteremia. A 23-valent pneumococcal vaccine is available to protect against the 23 S. pneumoniae serotypes responsible for 90% of reported bacteremic infections. Unfortunately, current S. pneumoniae serotype testing requires a large panel of expensive antisera, assay results may be subjective, and serotype cross-reactions are common. For this study, we designed an oligonucleotide-based DNA microarray to identify glycosyltransferase gene sequences specific to each vaccine-related serotype. Out of 56 isolates representing different serotypes, only one isolate, representing serotype 23A, was not detected correctly as it could not be distinguished from serotype 23F. Our data suggest that the microarray provides a more cost-effective and reliable way of monitoring pneumococcal capsular types.
Insights
A new DNA microarray accurately identifies Streptococcus pneumoniae serotypes, offering a cost-effective alternative to current methods. This advance aids in monitoring pneumococcal infections and vaccine effectiveness.
Area of Science:
- Microbiology
- Molecular Diagnostics
- Vaccinology
Background:
- Streptococcus pneumoniae is a leading cause of severe infections like meningitis and bacteremia.
- A 23-valent vaccine targets common S. pneumoniae serotypes, but accurate serotyping is challenging.
- Current serotype testing methods are expensive, subjective, and prone to cross-reactions.
Purpose of the Study:
- To develop a novel oligonucleotide-based DNA microarray for precise identification of S. pneumoniae serotypes.
- To evaluate the microarray's performance in distinguishing between vaccine-related serotypes.
Main Methods:
- Design of an oligonucleotide DNA microarray targeting glycosyltransferase gene sequences specific to S. pneumoniae serotypes.
- Testing the microarray against 56 S. pneumoniae isolates representing various serotypes.
Main Results:
- The DNA microarray successfully identified most S. pneumoniae serotypes.
- A single isolate of serotype 23A could not be distinguished from serotype 23F.
Conclusions:
- The developed DNA microarray offers a cost-effective and reliable method for S. pneumoniae serotype monitoring.
- This technology has the potential to improve surveillance of pneumococcal infections and vaccine efficacy.
Related Concept Videos
01:24Automated Microbial Diagnostics
01:25Rapid Identification of Pathogens